Chapter 13 of 25
- Confirm low-risk versus higher-risk features
- Select operation and nodal assessment
- Review final pathology
- Add postoperative therapy only when indicated
What you will learn
Compare surgical options; understand SHAPE and LACC evidence; prepare for recovery and postoperative decisions.
Different operations answer different needs
A cone biopsy may be sufficient for carefully selected microscopic disease with suitable margins and risk features. A simple hysterectomy removes the uterus and cervix. A radical hysterectomy also removes surrounding parametrial tissue and part of the upper vagina. Removal of the ovaries is a separate decision; hysterectomy does not automatically require it.
Lymph-node assessment may involve sentinel-node mapping, removal of selected nodes or a more extensive dissection, depending on disease and local expertise. Sentinel nodes are the first drainage nodes identified using a tracer; specialized pathological examination can detect small deposits. A failed mapping result or higher-risk situation may require additional assessment. Nodes help determine whether surgery remains the best treatment strategy.
Less radical surgery in a defined low-risk group
The randomized SHAPE trial studied 700 people with low-risk early cancers no larger than 2 cm and limited stromal invasion. Simple hysterectomy with nodal assessment was compared with radical hysterectomy. Three-year pelvic recurrence was 2.52% versus 2.17%, meeting the trial's noninferiority criterion; urinary problems were less frequent with the simpler operation. The trial does not support simple hysterectomy for all early cancers or omission of proper assessment.
Eligibility involves more than diameter. Histology, invasion, imaging and pathology must fit the chosen pathway. SHAPE also did not independently settle every question about the route of simple hysterectomy. Ask how closely your findings match the evidence, rather than assuming “smaller operation” is always sufficient.
Open versus minimally invasive radical hysterectomy
The LACC randomized trial found worse cancer outcomes with minimally invasive radical hysterectomy compared with open abdominal radical hysterectomy in the studied early-stage population. Open surgery therefore remains the reference approach when radical hysterectomy is required. A discussion of laparoscopic or robotic surgery must explain the relevant evidence and any exceptional selection; recovery advantages alone do not establish equal cancer safety.
This finding should not be indiscriminately applied to every diagnostic cone or to every simple hysterectomy. The operation, tumour characteristics and available evidence must be specified. Ask what procedure is planned, by which route, and why.
After surgery
Recovery can involve pain, fatigue, temporary bladder catheterization, constipation and restrictions on lifting or intercourse. Radical surgery can affect bladder nerves, sexual function and lymphatic drainage. Seek urgent advice for fever, heavy bleeding, increasing wound redness, inability to pass urine, a swollen painful leg or breathlessness. Follow the surgeon's individual activity and clot-prevention advice.
Final pathology may reveal positive nodes, involved margins or parametrial disease, which commonly prompt postoperative chemoradiation. Combinations of intermediate-risk features may lead to radiotherapy in appropriate cases. Not everyone needs additional treatment. If adjuvant therapy is likely before surgery, the team may consider definitive chemoradiation to avoid the added morbidity of combining major treatments.
Misconception and common question
“More radical surgery always gives better survival” is false. Can ovaries stay? Sometimes, depending on age, histology, ovarian risk and planned radiation. Preserving ovaries may preserve hormones, but removing the uterus prevents carrying a pregnancy.
Take-home messages
Confirm the exact operation and nodal plan. Discuss fertility and ovaries separately. Review final pathology before assuming treatment is complete.
References and review status
- Plante et al. SHAPE: simple versus radical hysterectomy, NEJM 2024
- Ramirez et al. LACC: minimally invasive versus abdominal radical hysterectomy, NEJM 2018
- Cibula et al. ESGO/ESTRO/ESP cervical cancer guidelines, 2023 update
Evidence/editorial check: 28 October 2026. AI-assisted preparation is separate from physician sign-off. Individual physician review is not recorded. Local approvals, resources and clinical guidance must be confirmed by the treating team.
Evidence scope and update policy